Choosing aesthetic devices is really a sequencing problem. Most clinics cannot fund every platform they would like in the first year, and the ones that try usually end up with equipment their case mix cannot fill. The question that produces a workable answer is not “which device is best” but “which capability do we add next, and what does it consume per treatment”.

This guide sets out how the category divides, which specifications decide each purchase, how to sequence an estate, and how to price ownership so the plan survives its first year.

What This Equipment Category Covers

The category covers devices used for aesthetic indications along with the accessories that keep them running. Practically, that means platforms for hair reduction, skin rejuvenation and resurfacing, vascular and pigment work, skin tightening, body contouring, microneedling and muscle stimulation, plus the handpieces, applicators, tips, filters and consumables each one depends on.

The useful way to read that list is by service line rather than by technology, because clinics sell treatments rather than platforms. Two devices that use different technologies can serve the same service line, and one device can serve several lines depending on the accessories fitted. Mapping your intended services against the equipment that can deliver them is what turns a catalogue into a plan.

Technology Options Compared

For buying purposes, the technologies differ in three ways that matter: what they can treat, how long an appointment runs, and what each treatment consumes.

Two structural choices recur. A multi-application console lowers capital and room requirements but concentrates risk in one unit and one supply chain. Separate single-purpose platforms cost more to buy and house, but a fault affects one service line instead of all of them. Which is right depends on how much downtime the clinic can absorb.

Specification Points That Decide the Buy

Whatever the technology, four specifications decide whether a purchase fits: indication coverage, appointment length, consumable consumption and verifiability.

Indication coverage is set by wavelength, filter band, tip design or focal depth, depending on the platform. Appointment length follows from spot size, coverage and cooling or coupling. Consumable consumption follows from the rated life of the delivery system divided into what one treatment uses. Verifiability depends on whether the platform reports counters, error history and self-tests, which is what allows condition to be checked before payment rather than after.

Write the specification before you look at listings, then reject anything that cannot evidence it. That reverses the usual order, in which a seller’s description quietly becomes the requirement, and it protects the decision from a persuasive presentation.

New Versus Pre-Owned

New, certified refurbished and as-is equipment differ in who carries discovery risk, not in quality ranking. A new unit carries manufacturer warranty and a full parts channel. A certified refurbished unit has been inspected, restored and performance tested, with the provider’s warranty behind it. An as-is unit transfers risk to the buyer for the lowest price.

For a first purchase, as-is condition is rarely the rational choice, because the clinic has no baseline for what normal behaviour looks like. For a second or third platform in an established practice with a service partner already engaged, a documented as-is unit can be the best value in the market.

Compare on total cost rather than purchase price. Add missing accessories, freight and installation, electrical work, calibration, training and first-year consumables. Once those lines are visible side by side, the ranking of offers frequently changes.

Service, Consumables and Downtime

Ownership cost is dominated by consumables and service. Tips, applicators, transducers, filters and lamps are consumable by design, and their rated life sets the cost of every treatment a clinic delivers.

Model it in three parts. Consumables: treatments per month multiplied by consumption per treatment, divided into rated life and priced at replacement. Preventive service: the interval specified for the platform, adjusted for throughput. Contingency: one unplanned intervention across three to four years.

Then price downtime explicitly, because it is the cost that catches clinics out. A device that cannot be serviced quickly stops producing revenue, and where a course is sold in advance the obligation continues. Published maintenance and device-safety guidance, such as that from ECRI, is a reasonable external check on whether the intervals described are realistic. Where a platform is the only one delivering a service line, either hold a spare consumable set or accept a planned gap in the calendar.

The sequence in which a clinic adds equipment also determines its maintenance burden. Each platform brings its own service interval, its own consumable cycle and its own parts exposure, and a clinic running four platforms carries four of each. That is the strongest argument for adding capability in phases rather than assembling a suite: the support load grows with the number of service relationships, not only with the number of devices, and managing four suppliers is a different operational problem from managing one.

Regulatory Position to Confirm

Regulatory status attaches to the model and its intended use, and it does not change when equipment is resold. What changes on a pre-owned purchase is the documentation you have to assemble yourself.

Confirm what the labelling permits for your market and verify the records independently. In the United States, clearances appear in the FDA 510(k) premarket notification database and establishments in the registration and listing database. Laser and light-based products also fall under the federal performance standard for light-emitting products, and the FDA guidance on device classification is a practical starting point for a modality new to the practice. Checking the model against the FDA recall and early alert listings takes minutes and occasionally changes the decision.

Where a clinic advertises outcomes, the claims must be substantiated; the FTC advertising guidance sets out the expectation in the United States.

How to Shortlist

A shortlist should start from the next capability you need rather than from the equipment you would like. Identify the service line with the strongest existing demand or the highest current referral leakage, and shortlist only what can deliver it.

Then filter on four questions. Does the platform cover the indications for that service line? Does a standard treatment fit your appointment length? What does it consume per treatment and does that leave a margin? Can it be serviced and resupplied locally? Platforms failing the last question should leave the list regardless of price, because the treatment line depends on uptime.

Test before committing. Run the protocol you intend to sell, record appointment time, consumable consumption and tolerance, then repeat with a second operator. Consistency across a team is as much a purchase criterion as clinical capability, particularly where a clinic plans to scale the service beyond its founding clinician.

Sequence the estate deliberately. One platform that fills its diary funds the next one; three platforms that each run at a third of capacity fund nothing. Three facts decide each step: what a treatment consumes, who services the platform, and whether consumables will still be supplied in year four.